---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-014899"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T12:22:20.190240+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech completes 1-for-100 reverse split; regains NYSE American listing compliance

## Summary
- Reverse stock split at 1-for-100 ratio effective June 12, 2025; new CUSIP 00901B303.
- NYSE American withdrew delisting determination; trading resuming June 17, 2025 under symbol AIM.
- Stock traded on OTC Pink (AIMID) during suspension; now reinstated on NYSE American.
- Reverse split authorized by stockholders Apr 30, 2025; Board fixed ratio May 29, 2025.
- Cash paid for fractional shares post-split.

## SEC filing metadata
- accession: 0001641172-25-014899
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000164117225014899/0001641172-25-014899-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000164117225014899/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-014899
- JSON: https://secwatch.observer/filing/0001641172-25-014899.json
- Plain text: https://secwatch.observer/filing/0001641172-25-014899.txt

## Key facts
- Listing & Compliance Notices
  AIM ImmunoTech Inc. received a nyse_american compliance regained notice regarding minimum bid price (rules 1003(f)(v)).
  - Exchange: nyse american
  - Notice: compliance regained
  - Deficiency: minimum bid price
  - Rules: 1003(f)(v)
  source text: June 11, 2025, AIM ImmunoTech Inc. (the “Company”) was notified by The NYSE American (the “Exchange”) that the Company has regained compliance with Section 1003(f)(v) of the NYSE American Company Guide (low selling price) and that trading in the Company’s Common Stock is expected to be reinstated on the Exchange on June 17, 2025 and the ticker symbol will be “AIM” upon reinstatement. The Company’s Common Stock currently trades on the OTC Pink under the symbol “AIMID”. The new CUSIP is 00901B303.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000164117225014899/0001641172-25-014899-index.htm
- Governance Changes
  AIM ImmunoTech Inc.: Filed amendment to Articles of Incorporation effecting a 1-for-100 reverse stock split (effective 2025-06-10).
  - Change: charter amendment
  - Effective: 2025-06-10
  source text: On June 10, 2025, the Company filed an amendment to its Articles of Incorporation effecting a reverse split of its outstanding shares of Common Stock on a one for 100 basis
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000164117225014899/0001641172-25-014899-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.